Skip to content

Case Study: Amendment for Officer Exculpation. Shareholder Meeting Advisory, Institutional Investor Intelligence, Retail Outreach

A medical specialist looking at a specimen

Assignment and Challenges

A small cap biotechnology company was facing a shareholder vote to amend its certificate of incorporation to allow for officer exculpation provisions. There were two significant obstacles to passing this vote:

  1. The vote requirement to pass the proposal was 2/3’s of the outstanding shares voting in favor. While this vote requirement is mathematically possible, from a practical standpoint this threshold is rarely achieved.
  2. Complicating matters, Glass Lewis recommended voting against these proposals, so negative votes were present at the start of the solicitation from institutions that follow Glass Lewis recommendations.

Solution

Knowing that this vote would be a challenge, Alliance Advisors brought three internal teams to the solicitation: Shareholder Meeting Advisory, Institutional Investor Intelligence and Retail Outreach.

At the onset, our Institutional Investor team began identifying all of the financial institutions, custodial relationships, and beneficial shareholders present on the Non-Objecting Beneficial Owners (NOBO) list. Using our proprietary data, Alliance Advisors was able to precisely identify the underlying investors behind each custodian.

Once the institutional investors were identified, our team began the outreach process to obtain voting instructions. Simultaneously, our Retail Outreach team began soliciting retail shareholders to facilitate telephone, text and email voting.

Both groups use a combination of our proprietary text-to-vote, email-to-vote and live telephone voting platforms. These technologies are designed to allow us to gather votes from both the institutional and retail shares, down to the smallest shareholder.

Results

Despite 7% of the outstanding shares voting against the proposal, Alliance Advisors was able to successfully deliver the required vote. A quorum of 84% of the outstanding shares was achieved with 67% of the outstanding shares voting in favor of the Officer Exculpation Amendment. By designing a campaign that focused on maximizing participation from both institutional and retail shareholders, Alliance Advisors was able to deliver an exceptionally high quorum to overcome the negative votes.

Institutional Investor Intelligence, Shareholder Meeting Advisory & Retail Outreach

NASDAQ Listed Small Cap Biotechnology Company

Alliance Advisors Logo Transparent

ニューヨーク•ワシントンD.C.• トロント •バンクーバー
ロンドン• ダーバン• 台北•香港•ソウル

ニューヨーク

800 3rd Ave 17階
ニューヨーク
NY 10022

Get in touch

グローバル本社

オーバールック・コーポレートセンター
クローブ・ロード150番地、スイート400
ニュージャージー州リトルフォールズ 07424

Get in touch

ヨーロッパ本社

タワー42
オールド・ブロード・ストリート25番地
ロンドン、EC2N 1HN

Get in touch

アジア太平洋地域本社

華懋中環23階
22 デ・ヴォー・ロード・セントラル、
香港セントラル

Get in touch

カナダ

400 – 22 E 5th Avenue
バンクーバー、ブリティッシュコロンビア州 V5T 1G8

Get in touch

アライアンス・アドバイザーズは、グローバルネットワークを通じて、株主総会アドバイザリー、株主エンゲージメント、報酬制度、ガバナンスおよびサステナビリティに関するサービスに特化した独立系アドバイザリー会社です。

私たちは、クライアントを最優先とした大胆な戦略の策定から実行に至るまで、その枠を超えて取り組み、成功へと導きます。

サービス

お問い合わせ